Search
for
Sort by
Research 121–150 of 1000+
- Patient satisfaction and adverse effects following the use of topical hair fiber fillers
- 27637 Strategies to minimize pain during platelet-rich plasma scalp injections
- Effective strategies to reduce pain during platelet-rich plasma scalp injections: A randomized split-scalp study
- Forging the Future: 2018 Alopecia Areata Research Summit Summary Report
- Monitoring Response to Platelet-Rich Plasma in Patients with Alopecia Areata with Optical Coherence Tomography: A Case Series
- Can we halt male androgenetic alopecia progression without antiandrogenic drugs?
- The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review
- Does Complement Have a Role in the Pathogenesis of Alopecia Areata?
- Beyond the Follicle: Exploring Psychiatric Comorbidities in Androgenetic Alopecia
- Laboratory Workup and Histopathology
- Severe lupus vasculitic neuropathy
- Baricitinib Provides Sustained, Long-Term Efficacy With Consistent Safety for Up to 5 Years of Treatment in Adults With Severe Alopecia Areata: Final Results From BRAVE-AA1 and BRAVE-AA2
- 62339 Improvement in anxiety and depression in adult patients with severe alopecia areata treated with deuruxolitinib: Pooled data from the THRIVE-AA1 and THRIVE-AA2 Phase 3 trials
- 60058 Change in patient-reported hair satisfaction during deuruxolitinib treatment of severe alopecia areata: Pooled data from the Phase 3 THRIVE-AA1 and THRIVE-AA2 trials
- 0447 Minoxidil for onychodystrophy: Can this hair loss remedy be a nail growth remedy?
- Patient satisfaction with hair regrowth in a study of ritlecitinib: a plain language summary
- The Use of Janus Kinase Inhibitors for Primary Neutrophilic Cicatricial Alopecias
- INDIVIDUAL ARTICLE: Insights on the Impact of Scalp Barrier Condition on Hair Health
- Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss
- Race and Ethnicity Sub-Groups of Alopecia Areata Patients have Differing Clinical Characteristics: TARGET-DERM AA
- Demographics and Disease Characteristics of Patients with Alopecia Areata with Comorbid Atopic Dermatitis, Vitiligo or Anxiety/Depression: TARGET-DERM AA
- Generic vs. Disease-Specific Patient Reported Outcome (PRO) Instruments for Assessing HRQoL Burden Among Patients Diagnosed with Alopecia Areata: Evidence from TARGET-DERM AA
- Evaluating Anti-Inflammatory Potential of Platelet-Rich Plasma in Scarring Alopecia: A Systematic Review
- Picking a Side: Preferential Laterality in Scalp Hair Density
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata
- Characteristics and Outcomes of Patients on Tofacitinib for Alopecia Areata or Rheumatoid Arthritis: A Retrospective Cohort Study
- Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
- Visualizing Severity of Alopecia Tool (SALT) scores in the clinical setting using patient images from a clinical trial
- The Challenge of Regrowing Hair With Lasers in Androgenetic Alopecia